ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript
ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.07532, expectations were $0.05.
Adma Biologics Inc. (ADMA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 6,433,369 | $42,460,235 | 0.73% | |
| 2. | D E Shaw D. E. Shaw | 5,381,718 | $35,519,339 | -18% | 0.03% |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 4,659,378 | $30,751,895 | -26% | 0.68% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 3,459,600 | $22,833,360 | +25% | 0.05% |
| 5. | Ophir Asset Management Steven Ng And Andrew Mitchell | 3,429,317 | $22,633,492 | 3.96% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.71 | 130,000 | 443,265 | 2023-08-30 | Filing | ||
| $3.90 | 25,000 | 277,401 | 2023-08-24 | Filing | ||
| $2.86 | 6,993 | 1,034,825 | 2022-12-09 | Filing | ||
| $2.86 | 14,982 | 1,143,426 | 2022-12-09 | Filing | ||
| $2.86 | 14,983 | 2,203,708 | 2022-12-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.72 | 100,000 | 2,081,475 | 2024-06-14 | Filing | ||
| $6.08 | 411,829 | 2,115,671 | 2024-03-19 | Filing | ||
| $6.01 | 49,887 | 2,527,500 | 2024-03-18 | Filing | ||
| $6.01 | 183,008 | 2,577,387 | 2024-03-15 | Filing | ||
| $6.05 | 448,276 | 2,760,395 | 2024-03-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,917,745 | $80,988,207 | 0% | |
| 2. | 12,891,875 | $58,271,275 | 0% | |
| 3. | 11,355,477 | $51,326,756 | 0.01% | |
| 4. | 9,483,590 | $42,865,827 | 0% | |
| 5. | 6,812,691 | $30,793,366 | 0.02% |
News See All
ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2023 Earnings Call Transcript
ADMA Biologics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $0.02.
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the ADMA Biologics Third Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, November 8, 2023.
ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the ADMA Biologics Second Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, August 9, 2023. [Operator Instructions].
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. And welcome to the ADMA Biologics First Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, May 10, 2023.
5 Best Stocks To Buy For A Stock Market Game
In this article, we will be taking a look at the 5 best stocks to buy for a stock market game.
20 Best Places to Live in NJ with Low Taxes
New Jersey is one of the smallest states in the U.S. in terms of area. The state covers 22,590 square kilometers, making it the fourth smallest state in the contiguous United States (CONUS).
5 Best Low-Priced Growth Stocks To Buy
ADMA Biologics, Inc. (NASDAQ:ADMA) is a biotech company whose shares have shown a remarkable performance over the past 12 months, gaining about 80% in value. In March, ADMA Biologics, Inc.
ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the ADMA Biologics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call on Thursday, March 23, 2023. .
12 Best Performing NASDAQ Stocks in 2022
The S&P 500 rose 0.6% to 3,844.82 on December 23, while the Nasdaq Composite gained 0.2% to close at 10,497.86. The Dow Jones Industrial Average also closed 176.44 points or 0.5% higher at 33,203.93.
Billionaire Hedge Funds
